MKMaayke A. de Koning

Maayke A. de Koning

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maayke A. de Koning has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prenatal Presentation of RMRP ‐Related Skeletal Dysplasia: Clinical and Genomic Expansion

    by Radhakrishnan Periyasamy, Pascal Joset, H. E. Veenstra‐Knol, Nicole Corsten‐Janssen, Tuula Rinne, Irene Valenzuela, Marta Codina‐Solà, Carlota Rodó, Marjolaine Willems, Constance Wells, et al.

    The RNA subunit of the mitochondrial RNA processing endoribonuclease complex is encoded by RMRP . Biallelic variants in RMRP are known for anauxetic dysplasia 1 (AD), cartilage‐hair hypoplasia (CHH), and metaphyseal dysplasia without hypotrichosis. More than 140 variants in RMRP have been reported in patients with RMRP‐related disorders. Genotype–phenotype correlation is poorly understood. Patients documented are predominantly children and young adults, and prenatal onset of clinical symptoms has been reported in only a limited number of cases. We identified biallelic variants in RMRP in a family with two affected fetuses with lethal skeletal dysplasia. We collected eight more patients who developed prenatal symptoms of RMRP‐related disorders. We describe extensive clinical phenotyping, an atlas of radiological images, and genetic results of 10 novel fetal cases presenting with CHH and compare our findings with seven further previously reported fetuses. Despite the variability of clinical signs in CHH, a severe fetal presentation may be suspected as early as 16 weeks of gestation based on skeletal findings. We observed that variants clustering at the paired domains of the RMRP transcript and/or promoter regions preferably lead to early severe phenotypes. The molecular diagnosis may be missed, as current exome captures do not always include RNA genes.

  • Open Access

    Increasing clinical utility of prenatal exome sequencing: the potential power of phenotype-driven Artificial Intelligence analysis

    by Manon Suerink, Mariette Hoffer, Alexander Dingemans, Ilse Feenstra, Malou Heijligers, Dineke Westra, Helger Yntema, Galuh Astuti, Mariet Elting, Marielle van Gijn, et al.

    Prenatal exome sequencing (pES) is challenging due to rapid turnaround requirements and limited phenotype information. Analysis strategies span gene panels through exome-wide review, with Artificial Intelligence (AI) as optional support. We evaluated how these approaches impact clinical utility of pES. We prospectively included 233 parental-foetal trios. Analysis results from virtual gene panels (Foetal Anomalies and DDG2P) and an AI-driven variant interpretation platform, were compared with clinical diagnostic work-up, assessing causative variants, phenotype-relevant variants of uncertain significance (VUS) and incidental findings (IF). Diagnostic yield of AI and both gene panels was 14.2% (N = 33 cases). AI and gene panel analysis both missed one diagnosis that was made in clinical diagnostic work-up. AI ranked all causative variants in the top five, except for a low-level mosaic variant below the review threshold. Rates of VUS and IF did not differ significantly across approaches. The number of prioritized variants did not correlate with HPO-term specificity or number, while newer AI versions prioritized significantly fewer variants. Alternative analyses strategies had similar diagnostic yield compared to routine diagnostic work-up. Phenotype-driven AI reliably prioritized causal variants and could help streamline variant interpretation. These outcomes show the potential of phenotype-driven AI to increase clinical utility.

    • 1 April 2026
      • Vol. 35  (2) , e70187
    Open Access

    Experiences of Dutch parents undergoing prenatal genomic testing for fetal structural anomalies: A prospective qualitative analysis.

    by Maayke A de Koning, Sarah Long, Holly E Evans, Lauren Kelada, Gijs W E Santen, Tony Roscioli, Manon Suerink

    Prenatal Exome Sequencing (pES) increases the diagnostic rate for genetic disorders in pregnancies with structural abnormalities and substantially impacts parental decision-making regarding pregnancy continuation or termination. Previous qualitative research on parental experiences of pES has typically been performed several months after results were returned to parents. Moreover, parental experiences of pES might be dependent on cultural aspects and country-specific healthcare systems. This research therefore prospectively explores experiences of families undergoing pES in the Netherlands. Expectant parents undergoing pES because of ultrasound anomalies were invited to participate with two interviews: interview T1 after counseling for genetic testing but prior to return of results and interview T2 six months after return of results. We translated a previously designed Australian interview script, used in similar research, to Dutch, including four open-end and two multiple-choice questions in addition to demographic details. An inductive content analysis approach was used for coding and analysis. Twelve families were interviewed at T1, of which five participants agreed to T2 follow-up interviews. We constructed six content categories of importance: (1) Prenatal feelings of fear, uncertainty, guilt, and anxiety; (2) conflicting feelings in the face of (un)certainty; (3) overall satisfaction with genetic counseling; (4) decision-making influenced by desire for information about their child's quality of life; (5) decision-making influenced by reproductive options and family planning; and (6) importance of empathy, kindness, and clear communication from friends, family, and healthcare professionals. Many content categories show overlap to previous research. However, families in this cohort did not explicitly express negative opinions about waiting on results which is possibly explained by concurrently running multiple genetic testing modalities. Moreover, all participants mentioned positive experiences of the provided healthcare, partly because of swift multidisciplinary collaboration. This study highlights the value of pre-test counseling by clinical geneticists and shows the need for close collaboration between feto-maternal specialists, clinical geneticists, and laboratory specialists.

  • Open Access

    Experiences of Dutch parents undergoing prenatal genomic testing for fetal structural anomalies: A prospective qualitative analysis

    by Maayke A. de Koning, Sarah Long, Holly E. Evans, Lauren Kelada, Gijs W. E. Santen, Tony Roscioli, Manon Suerink

    Prenatal Exome Sequencing (pES) increases the diagnostic rate for genetic disorders in pregnancies with structural abnormalities and substantially impacts parental decision‐making regarding pregnancy continuation or termination. Previous qualitative research on parental experiences of pES has typically been performed several months after results were returned to parents. Moreover, parental experiences of pES might be dependent on cultural aspects and country‐specific healthcare systems. This research therefore prospectively explores experiences of families undergoing pES in the Netherlands. Expectant parents undergoing pES because of ultrasound anomalies were invited to participate with two interviews: interview T1 after counseling for genetic testing but prior to return of results and interview T2 six months after return of results. We translated a previously designed Australian interview script, used in similar research, to Dutch, including four open‐end and two multiple‐choice questions in addition to demographic details. An inductive content analysis approach was used for coding and analysis. Twelve families were interviewed at T1, of which five participants agreed to T2 follow‐up interviews. We constructed six content categories of importance: (1) Prenatal feelings of fear, uncertainty, guilt, and anxiety; (2) conflicting feelings in the face of (un)certainty; (3) overall satisfaction with genetic counseling; (4) decision‐making influenced by desire for information about their child's quality of life; (5) decision‐making influenced by reproductive options and family planning; and (6) importance of empathy, kindness, and clear communication from friends, family, and healthcare professionals. Many content categories show overlap to previous research. However, families in this cohort did not explicitly express negative opinions about waiting on results which is possibly explained by concurrently running multiple genetic testing modalities. Moreover, all participants mentioned positive experiences of the provided healthcare, partly because of swift multidisciplinary collaboration. This study highlights the value of pre‐test counseling by clinical geneticists and shows the need for close collaboration between feto‐maternal specialists, clinical geneticists, and laboratory specialists.

  • Open Access

    “The Way We Do Things is Unsustainable” —Exploring Symptoms of Burnout Among Healthcare Professionals in Prenatal Genomics

    by Maayke de Koning, Sarah Long, Marit de Vries, Holly Evans, Lauren Kelada, Monique Haak, Gemma Fernihough, Gijs Santen, Manon Suerink, Tony Roscioli

    Objectives: This research explored a cross‐country comparison of qualitative and quantitative data assessing the experiences of prenatal genomic healthcare professionals (HCP) in Australia and the Netherlands. Method: The interview script included open‐ended questions on work experience, validated scales on compassion fatigue and stress, and demographic details. Content analysis with an inductive coding approach was used for the coding and analysis of qualitative data. Quantitative data were compared between professions and countries, using a one‐way ANCOVA. Results: Quantitative data were obtained from 93 participants and qualitative data from a subset of 63 participants, recruited from the departments of clinical genetics, maternal‐fetal medicine and genomic laboratories. The following themes were constructed: (1) Advancements in prenatal genomics increase diagnostic rates but cause increased workloads; (2) Benefits and drawbacks of the current healthcare system; (3) The burden of equivocality: high stakes and ambiguous findings; and (4) Multidisciplinary teamwork, support and supervision may improve working conditions. There were no significant differences in compassion fatigue between professions, but Australian HCPs experienced significantly more symptoms of burnout and secondary traumatic stress than Dutch HCPs. Conclusion: Although participants had overall positive views and experiences, with high levels of job satisfaction and low levels of compassion fatigue, additional resources are required to minimize professional burnout while dealing with increasing demands.


  • Prenatal Variants of Uncertain Significance (VUS): to report or not to report?

    by Maayke A. de Koning, Malgorzata I. Srebniak, Esther J. Oldekamp, Denise Hahn, Karin E. M. Diderich, Hennie T. Bruggenwirth, Gijs W. E. Santen, Mariëtte J. V. Hoffer, Manon Suerink

    Prenatal Exome Sequencing (pES) has a significant diagnostic yield but time pressure and limited phenotypic information make interpretation of Variants of Uncertain Significance (VUS) more challenging than in a postnatal setting. We share our experiences of prenatal reporting of highly suspicious VUS. We retrospectively analyzed pregnancies in which VUS identified by pES were reported to parents during pregnancy in two Dutch academic medical hospitals. During the study period, 31 VUS in 28 genes were reported in 27 pregnancies. Cases were assigned to one of five groups based on consistency of prenatal phenotypes with gene-associated diagnoses. The implications of VUS included clinical evaluation of parental carriers (N = 4), additional screening of proband (N = 2), influencing parental decision-making (N = 11) and/or prompting confirmatory testing (N = 10). Reanalysis with currently available data resulted in reclassification of seven variants, five of which were upgraded to (likely) pathogenic. Although we do not recommend routine disclosure, our data suggest that prenatal reporting of VUS can be valuable in exceptional cases. Stringent selection was applied and only a minority of reported VUS was reclassified as (likely) pathogenic. Therefore, a careful individual assessment of each VUS case remains imperative and multidisciplinary meetings should be an integral part of prenatal VUS management.


  • De novo heterozygous missense variants in CELSR1 as cause of fetal pleural effusions and progressive fetal hydrops

    by Maayke A de Koning, Paula A Pimienta Ramirez, Monique C Haak, Xiao Han, Martina Ha Ruiterkamp-Versteeg, Nicole de Leeuw, Ulrich A Schatz, Moneef Shoukier, Esther Rieger-Fackeldey, Javier U Ortiz, et al.

    Fetal hydrops as detected by prenatal ultrasound usually carries a poor prognosis depending on the underlying aetiology. We describe the prenatal and postnatal clinical course of two unrelated female probands in whom de novo heterozygous missense variants in the planar cell polarity gene CELSR1 were detected using exome sequencing. Using several in vitro assays, we show that the CELSR1 p.(Cys1318Tyr) variant disrupted the subcellular localisation, affected cell-cell junction, impaired planar cell polarity signalling and lowered proliferation rate. These observations suggest that deleterious rare CELSR1 variants could be a possible cause of fetal hydrops.


  • Open Access

    Prenatal exome sequencing: A useful tool for the fetal neurologist

    by Maayke A. de Koning, Mariëtte J. V. Hoffer, Esther A. R. Nibbeling, Emilia K. Bijlsma, Menno J. P. Toirkens, Phebe N. Adama‐Scheltema, E. Joanne Verweij, Marieke B. Veenhof, Gijs W. E. Santen, Cacha M. P. C. D. Peeters‐Scholte

    Prenatal exome sequencing (pES) is a promising tool for diagnosing genetic disorders when structural anomalies are detected on prenatal ultrasound. The aim of this study was to investigate the diagnostic yield and clinical impact of pES as an additional modality for fetal neurologists who counsel parents in case of congenital anomalies of the central nervous system (CNS). We assessed 20 pregnancies of 19 couples who were consecutively referred to the fetal neurologist for CNS anomalies. pES had a diagnostic yield of 53% (10/19) with most diagnosed pregnancies having agenesis or hypoplasia of the corpus callosum (7/10). Overall clinical impact was 63% (12/19), of which the pES result aided parental decision making in 55% of cases (6/11), guided perinatal management in 75% of cases (3/4), and was helpful in approving a late termination of pregnancy request in 75% of cases (3/4). Our data suggest that pES had a high diagnostic yield when CNS anomalies are present, although this study is limited by its small sample size. Moreover, pES had substantial clinical impact, which warrants implementation of pES in the routine care of the fetal neurologist in close collaboration with gynecologists and clinical geneticists.